Trial intelligence / Profile preview

Oral Zinc Sulfate for Clearance of Cervical LSIL

TCTR20250406002Phase 3Active, not recruiting

Sponsor
Bhumibol Adulyadej Hospital
Start
May 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of zinc in cervical intraepithelial neoplasia (CIN), sponsored by Bhumibol Adulyadej Hospital. Started May 2025; status: active, not recruiting.

02

Drugs

zinc
03

Conditions

cervical intraepithelial neoplasia (CIN)

Beyond the preview

Go deeper on TCTR20250406002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250406002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call